USPatentGranted
B2

Pharmaceutical formulation containing gelling agent

Granted 14 Apr 2015 · 4 office actions

Life of the patent

13 dated events
⤢ drag to zoom200520102015202020252030ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Claims

9 · 3 independent · depth 2
123456789
9 granted claims

Classifications

13 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/192
  • A61K9/20
  • A61K47/10
  • A61K47/36
  • A61K31/167
  • A61K45/06
  • A61K31/439
  • A61K47/38
  • A61K9/00
  • A61K31/485
USPC · US Patent Classification
424/464514/282424/465

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJan 2013Apr 2013Jul 2013Oct 2013Jan 2014Apr 2014Jul 2014Oct 2014Jan 2015Apr 2015USPTOApplicantNon-final rejectionResponse after non-finalFinal rejectionResponse after finalNotice of appeal filedRequest for continued examinationNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
2.2 y
791 days filing → grant
Office actions
2
non-final + final
Responses
3
1 RCE
Examiner
Robert A Wax
art unit 1615 · TC 1600
Citations: 345 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

2 priority documents
Priority
6 Aug 2001
earliest claimed
›Priority documents — 2
TypeDocumentDate
provisionalUS 603105346 Aug 2001
related publicationUS 20130261143 A13 Oct 2013

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock